Clinical trials
Phase 3 Down Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 2 |
| Eisai Inc. | 2 |
| LuMind IDSC Foundation | 1 |
| National Cancer Institute (NCI) | 1 |
| New York State Institute for Basic Research | 1 |
| University of Colorado, Denver | 1 |
| University of Illinois at Chicago | 1 |
| Woolfson Eye Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Down Syndrome | 10 |
| Cognitive Dysfunction | 2 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Alzheimer Disease | 1 |
| Burkitt Lymphoma | 1 |
| Corneal Diseases | 1 |
| Keratoconus | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.